Skeletal effects of 5-year high-dose cyclical etidronate in patients with pseudoxanthoma elasticum.

Haverkamp M, van Weert AJ, Foppen W, Bunk S, Visseren FLJ, Beg MF, Popuri K, Papapoulos SE, Spiering W, de Jong PA

Open source

DOI
10.1016/j.bone.2026.118088
Published
2026 Sep 15
Container
Bone
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bone.2026.118088,
  title = {Skeletal effects of 5-year high-dose cyclical etidronate in patients with pseudoxanthoma elasticum.},
  author = {Haverkamp M and van Weert AJ and Foppen W and Bunk S and Visseren FLJ and Beg MF and Popuri K and Papapoulos SE and Spiering W and de Jong PA},
  year = {2026},
  journal = {Bone},
  doi = {10.1016/j.bone.2026.118088},
  url = {https://doi.org/10.1016/j.bone.2026.118088}
}

RIS

TY  - JOUR
TI  - Skeletal effects of 5-year high-dose cyclical etidronate in patients with pseudoxanthoma elasticum.
AU  - Haverkamp M
AU  - van Weert AJ
AU  - Foppen W
AU  - Bunk S
AU  - Visseren FLJ
AU  - Beg MF
AU  - Popuri K
AU  - Papapoulos SE
AU  - Spiering W
AU  - de Jong PA
PY  - 2026
JO  - Bone
DO  - 10.1016/j.bone.2026.118088
UR  - https://doi.org/10.1016/j.bone.2026.118088
ER  - 

APA

M, H., AJ, V. W., W, F., S, B., FLJ, V., MF, B., K, P., SE, P., W, S., & PA, D. J. (2026). Skeletal effects of 5-year high-dose cyclical etidronate in patients with pseudoxanthoma elasticum.. Bone. https://doi.org/10.1016/j.bone.2026.118088

Source records